MA49794A - Composition utilisée dans le traitement prophylactique et thérapeutique de troubles de l'appareil cardiovasculaire - Google Patents
Composition utilisée dans le traitement prophylactique et thérapeutique de troubles de l'appareil cardiovasculaireInfo
- Publication number
- MA49794A MA49794A MA049794A MA49794A MA49794A MA 49794 A MA49794 A MA 49794A MA 049794 A MA049794 A MA 049794A MA 49794 A MA49794 A MA 49794A MA 49794 A MA49794 A MA 49794A
- Authority
- MA
- Morocco
- Prior art keywords
- prophylactic
- disorders
- composition used
- therapeutic treatment
- cardiovascular system
- Prior art date
Links
- 210000000748 cardiovascular system Anatomy 0.000 title 1
- 230000000069 prophylactic effect Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/1592—Iron
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/161—Magnesium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/714—Vitamin K
- A23V2250/7144—Vitamin K2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102017000085412A IT201700085412A1 (it) | 2017-07-26 | 2017-07-26 | Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare |
Publications (1)
Publication Number | Publication Date |
---|---|
MA49794A true MA49794A (fr) | 2020-06-03 |
Family
ID=60451085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA049794A MA49794A (fr) | 2017-07-26 | 2018-07-26 | Composition utilisée dans le traitement prophylactique et thérapeutique de troubles de l'appareil cardiovasculaire |
Country Status (18)
Country | Link |
---|---|
US (1) | US20200206157A1 (fr) |
EP (1) | EP3657963A1 (fr) |
JP (2) | JP2020528888A (fr) |
KR (1) | KR20200032691A (fr) |
CN (1) | CN111031813A (fr) |
BR (1) | BR112020000902B1 (fr) |
CA (1) | CA3070659A1 (fr) |
CL (1) | CL2020000170A1 (fr) |
CO (1) | CO2020000526A2 (fr) |
EA (1) | EA202090069A1 (fr) |
IL (1) | IL272138B2 (fr) |
IT (1) | IT201700085412A1 (fr) |
JO (1) | JOP20200012A1 (fr) |
MA (1) | MA49794A (fr) |
MX (1) | MX2020000806A (fr) |
PH (1) | PH12020550031A1 (fr) |
WO (1) | WO2019021232A1 (fr) |
ZA (1) | ZA202000461B (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11202012070YA (en) | 2018-06-08 | 2021-01-28 | Epizon Pharma Inc | Methods and compositions for preventing or treating tissue calcification |
JP2021527129A (ja) | 2018-06-08 | 2021-10-11 | エピゾン・ファーマ・インコーポレイテッドEpizon Pharma, Inc. | カルシフィラキシスを予防または治療するための方法および組成物 |
WO2023232643A1 (fr) | 2022-05-31 | 2023-12-07 | Region Syddanmark | Vitamine k2 destinée à être utilisée dans le traitement de la calcification des artères coronaires |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3860849B2 (ja) * | 1994-04-28 | 2006-12-20 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗動脈硬化治療剤 |
WO1996039053A2 (fr) * | 1995-06-06 | 1996-12-12 | Campbell Soup Company | Complements alimentaires a base de mineraux pour repas dietetique |
US6361800B1 (en) * | 2000-04-13 | 2002-03-26 | Cooper Concepts, Inc. | Multi-vitamin and mineral supplement |
GB0220182D0 (en) * | 2002-08-30 | 2002-10-09 | Cardiovascular Res Inst Maastr | Organic compounds |
AU2004287440A1 (en) * | 2003-10-28 | 2005-05-19 | Emory University | Dialysates and methods and systems related thereto |
US20050281888A1 (en) * | 2004-06-16 | 2005-12-22 | Chandra Ranjit K | Nutritional supplement for infants |
US20060134226A1 (en) * | 2004-11-16 | 2006-06-22 | Todd Leonard | Compositions useful to treat ocular neovascular diseases and macular degeneration |
DK1973552T3 (en) * | 2005-12-23 | 2017-08-07 | Ajay Gupta | Parenteral nutritional composition containing iron |
CN101374416A (zh) * | 2006-01-30 | 2009-02-25 | 环亚有限公司 | 逆转、防止、延迟或稳定软组织钙化的方法 |
US20100021573A1 (en) * | 2008-07-22 | 2010-01-28 | Michael J Gonzalez | Compositions and methods for the prevention of cardiovascular disease |
JPWO2010073642A1 (ja) * | 2008-12-25 | 2012-06-07 | 有限会社 アイ・ビー・イー | 生物活性剤、医薬、化粧品、鮮度保持剤、および植物および動物の発育促進剤 |
CN103687495A (zh) * | 2011-05-20 | 2014-03-26 | 弗里斯兰品牌有限公司 | 包含维生素k2的组合物 |
ITMI20121350A1 (it) * | 2012-07-31 | 2014-02-01 | Alesco Srl | Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro. |
EP2886129A1 (fr) * | 2013-12-20 | 2015-06-24 | VitaK B.V. | Prévention et action contraire de risque de thrombose induite par le régime alimentaire |
EP3258924A2 (fr) * | 2015-02-20 | 2017-12-27 | VitaK B.V. | Statut en vitamine k et fonction capillaire |
-
2017
- 2017-07-26 IT IT102017000085412A patent/IT201700085412A1/it unknown
-
2018
- 2018-07-26 US US16/631,426 patent/US20200206157A1/en active Pending
- 2018-07-26 BR BR112020000902-4A patent/BR112020000902B1/pt active IP Right Grant
- 2018-07-26 JP JP2020502672A patent/JP2020528888A/ja active Pending
- 2018-07-26 IL IL272138A patent/IL272138B2/en unknown
- 2018-07-26 CA CA3070659A patent/CA3070659A1/fr active Pending
- 2018-07-26 MA MA049794A patent/MA49794A/fr unknown
- 2018-07-26 MX MX2020000806A patent/MX2020000806A/es unknown
- 2018-07-26 KR KR1020207001554A patent/KR20200032691A/ko not_active Application Discontinuation
- 2018-07-26 EA EA202090069A patent/EA202090069A1/ru unknown
- 2018-07-26 WO PCT/IB2018/055586 patent/WO2019021232A1/fr active Application Filing
- 2018-07-26 EP EP18762623.9A patent/EP3657963A1/fr active Pending
- 2018-07-26 JO JOP/2020/0012A patent/JOP20200012A1/ar unknown
- 2018-07-26 CN CN201880045110.6A patent/CN111031813A/zh active Pending
-
2020
- 2020-01-17 PH PH12020550031A patent/PH12020550031A1/en unknown
- 2020-01-17 CO CONC2020/0000526A patent/CO2020000526A2/es unknown
- 2020-01-20 CL CL2020000170A patent/CL2020000170A1/es unknown
- 2020-01-23 ZA ZA2020/00461A patent/ZA202000461B/en unknown
-
2023
- 2023-05-02 JP JP2023076299A patent/JP2023090869A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
PH12020550031A1 (en) | 2021-02-08 |
IL272138A (en) | 2020-03-31 |
CA3070659A1 (fr) | 2019-01-31 |
JOP20200012A1 (ar) | 2020-01-26 |
US20200206157A1 (en) | 2020-07-02 |
WO2019021232A1 (fr) | 2019-01-31 |
JP2020528888A (ja) | 2020-10-01 |
IL272138B2 (en) | 2023-09-01 |
IL272138B1 (en) | 2023-05-01 |
IT201700085412A1 (it) | 2019-01-26 |
ZA202000461B (en) | 2021-03-31 |
CO2020000526A2 (es) | 2020-02-18 |
BR112020000902A2 (pt) | 2020-07-21 |
EA202090069A1 (ru) | 2020-04-10 |
EP3657963A1 (fr) | 2020-06-03 |
JP2023090869A (ja) | 2023-06-29 |
CL2020000170A1 (es) | 2020-10-30 |
CN111031813A (zh) | 2020-04-17 |
MX2020000806A (es) | 2020-08-17 |
BR112020000902B1 (pt) | 2024-03-12 |
KR20200032691A (ko) | 2020-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA50417A (fr) | Procédés d'utilisation d'inhibiteurs de l'ehmt2 dans le traitement ou la prévention de troubles du sang | |
MA51200A (fr) | Nouveaux composés et compositions pharmaceutiques associées pour le traitement de maladies | |
MA45481A (fr) | Utilisation d'exosomes pour le traitement de maladies | |
MA46052A (fr) | Modulateurs du récepteur hormonal pour le traitement d'états et de troubles métaboliques | |
MA45089A (fr) | Utilisation d'indazoles 2-substitués pour le traitement et la prophylaxie de maladies auto-immunes | |
FR3032353B1 (fr) | Composition pharmaceutique et dispositif pour le traitement de la douleur | |
MA49069A (fr) | Procédés et compositions pour le traitement d'apnée du sommeil | |
MA47688A (fr) | Compositions utiles dans le traitement de l'amyotrophie spinale | |
MA50849A (fr) | Substances et procédés pour le traitement d'hémoglobinopathies | |
MA50763A (fr) | Compositions d'acides aminés et méthodés de traitement de maladies et troubles musculaires | |
MA49368A (fr) | Imidazopyrimidines à substitution diazabicyclique et leur utilisation pour traiter des maladies des voies respiratoires | |
MA43982A (fr) | Anticorps anti-tnf, compositions, méthodes et utilisation pour le traitement ou la prévention du diabète de type 1 | |
MA41996A (fr) | Utilisation de triméthazine dans la préparation de médicaments pour la prévention et le traitement de maladies hépatiques | |
MA47069A (fr) | Formes pharmaceutiques contenant des inhibiteurs des canaux task-1 et task-3 et leur utilisation pour le traitement de troubles respiratoires | |
MA44762A (fr) | Sémaglutide utilisé dans le traitement de maladies cardiovasculaires | |
MA51056A (fr) | Compositions et méthodes pour le traitement d'affections métaboliques | |
MA49794A (fr) | Composition utilisée dans le traitement prophylactique et thérapeutique de troubles de l'appareil cardiovasculaire | |
MA44413A (fr) | Composition pharmaceutique utilisée pour le traitement thérapeutique du cancer et ses complications | |
MA47074A (fr) | Formes pharmaceutiques comprenant des inhibiteurs de canaux de task-1 et task-3 et leur utilisation pour le traitement des troubles respiratoires | |
MA52971A (fr) | Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle | |
MA50233A (fr) | Mic-1 et glp-1 destinés à être utilisés dans le traitement de l'obésité | |
MA50905A (fr) | Composés et compositions pharmaceutiques de ceux-ci destinés à être utilisés dans le traitement de maladies fibrotiques | |
HK1250629A1 (zh) | 用於治療人乳頭狀瘤病毒皮膚感染的含乙酰水楊酸的組合物和醫療裝置 | |
MA56392A (fr) | Dérivés de 2h-indazole et leur utilisation dans le traitement de maladies | |
MA41629A (fr) | Compositions et méthodes d'utilisation de l'hormone anti-müllérienne pour le traitement de l'infertilité |